“Spare-spleen-uximab” for chronic ITP
- 15 August 2008
- journal article
- editorial
- Published by American Society of Hematology in Blood
- Vol. 112 (4) , 925-926
- https://doi.org/10.1182/blood-2008-06-159335
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- First‐line therapies for immune thrombocytopenic purpura: re‐evaluating the need to treatEuropean Journal of Haematology, 2008
- Should rituximab be used before or after splenectomy in patients with immune thrombocytopenic purpura?Current Opinion in Hematology, 2007
- Response to B-cell–depleting therapy with rituximab reverts the abnormalities of T-cell subsets in patients with idiopathic thrombocytopenic purpuraBlood, 2007
- Late spontaneous remissions in severe adult autoimmune thrombocytopeniaAnnals of Hematology, 2007
- Systematic Review: Efficacy and Safety of Rituximab for Adults with Idiopathic Thrombocytopenic PurpuraAnnals of Internal Medicine, 2007
- The efficacy and safety of B‐cell depletion with anti‐CD20 monoclonal antibody in adults with chronic immune thrombocytopenic purpuraBritish Journal of Haematology, 2004
- One-Sample Multiple Testing Procedure for Phase II Clinical TrialsPublished by JSTOR ,1982